- Home
- CAN vs ABSI Comparison
CAN vs ABSI Comparison
Compare CAN & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- ABSI
- Stock Information
- Founded
- CAN 2013
- ABSI 2011
- Country
- CAN Singapore
- ABSI United States
- Employees
- CAN N/A
- ABSI N/A
- Industry
- CAN Semiconductors
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CAN Technology
- ABSI Health Care
- Exchange
- CAN Nasdaq
- ABSI Nasdaq
- Market Cap
- CAN 330.5M
- ABSI 338.0M
- IPO Year
- CAN 2019
- ABSI 2021
- Fundamental
- Price
- CAN $0.74
- ABSI $2.39
- Analyst Decision
- CAN Strong Buy
- ABSI Strong Buy
- Analyst Count
- CAN 6
- ABSI 5
- Target Price
- CAN $2.50
- ABSI $7.98
- AVG Volume (30 Days)
- CAN 32.6M
- ABSI 4.4M
- Earning Date
- CAN 08-14-2025
- ABSI 08-12-2025
- Dividend Yield
- CAN N/A
- ABSI N/A
- EPS Growth
- CAN N/A
- ABSI N/A
- EPS
- CAN N/A
- ABSI N/A
- Revenue
- CAN $345,360,000.00
- ABSI $4,138,000.00
- Revenue This Year
- CAN $90.25
- ABSI $44.71
- Revenue Next Year
- CAN $42.94
- ABSI $374.26
- P/E Ratio
- CAN N/A
- ABSI N/A
- Revenue Growth
- CAN 82.40
- ABSI 27.32
- 52 Week Low
- CAN $0.53
- ABSI $2.01
- 52 Week High
- CAN $3.27
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CAN 51.63
- ABSI 33.33
- Support Level
- CAN $0.64
- ABSI $2.50
- Resistance Level
- CAN $0.80
- ABSI $2.73
- Average True Range (ATR)
- CAN 0.05
- ABSI 0.18
- MACD
- CAN 0.00
- ABSI -0.04
- Stochastic Oscillator
- CAN 59.38
- ABSI 1.94
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.